| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |